| Cubic phase gels as drug delivery systems JC Shah, Y Sadhale, DM Chilukuri Advanced drug delivery reviews 47 (2-3), 229-250, 2001 | 796 | 2001 |
| Hydrolysis in pharmaceutical formulations KC Waterman, RC Adami, KM Alsante, AS Antipas, DR Arenson, ... Pharmaceutical development and technology 7 (2), 113-146, 2002 | 184 | 2002 |
| Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release ES Park, M Maniar, JC Shah Journal of Controlled Release 52 (1-2), 179-189, 1998 | 134 | 1998 |
| Polyanhydrides: synthesis and characterization AJ Domb, S Amselem, J Shah, M Maniar Biopolymers I, 93-141, 1993 | 119 | 1993 |
| Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide JC Shah, JR Chen, D Chow Pharmaceutical research 6, 408-412, 1989 | 109 | 1989 |
| Stabilization of insulin against agitation-induced aggregation by the GMO cubic phase gel Y Sadhale, JC Shah International journal of pharmaceutics 191 (1), 51-64, 1999 | 101 | 1999 |
| Preformulation study of etoposide: II. Increased solubility and dissolution rate by solid-solid dispersions JC Shah, JR Chen, D Chow International Journal of Pharmaceutics 113 (1), 103-111, 1995 | 99 | 1995 |
| Degradable polymers for site‐specific drug delivery A Domb, S Amselem, J Shah, M Maniar Polymers for Advanced Technologies 3 (6), 279-292, 1992 | 98 | 1992 |
| Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure–pharmacokinetic relationships (QSPKR) C Durairaj, JC Shah, S Senapati, UB Kompella Pharmaceutical research 26, 1236-1260, 2009 | 92 | 2009 |
| Pharmacokinetics of oxytetracycline in the white shrimp, Litopenaeus setiferus LA Reed, TC Siewicki, JC Shah Aquaculture 232 (1-4), 11-28, 2004 | 87 | 2004 |
| Biological activity of insulin in GMO gels and the effect of agitation Y Sadhale, JC Shah International journal of pharmaceutics 191 (1), 65-74, 1999 | 84 | 1999 |
| Oral pharmaceutical dosage forms JJ Scicinski, WW Van Osdol, HC Su, MH Arenberg, J Shah US Patent App. 12/590,195, 2010 | 75 | 2010 |
| Analysis of permeation data: evaluation of the lag time method JC Shah International Journal of pharmaceutics 90 (2), 161-169, 1993 | 75 | 1993 |
| Glyceryl monooleate cubic phase gel as chemical stability enhancer of cefazolin and cefuroxime Y Sadhale, JC Shah Pharmaceutical development and technology 3 (4), 549-556, 1998 | 70 | 1998 |
| PERCUTANEOUS PERMEATION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) FROM COMMERCIAL MOSQUITO REPELLENTS AND THE EFFECT OF SOLVENT J Stinecipher, J Shah Journal of toxicology and environmental health 52 (2), 119-135, 1997 | 70 | 1997 |
| Injectable depot formulations and methods for providing sustained release of poorly soluble drugs comprising nanoparticles JC Shah, PS Shah, DR Wagner, P Wisniecki US Patent App. 11/911,432, 2008 | 56 | 2008 |
| Reduction in skin permeation of N, N-diethyl-m-toluamide (DEET) by altering the skin/vehicle partition coefficient JS Ross, JC Shah Journal of controlled release 67 (2-3), 211-221, 2000 | 55 | 2000 |
| Novel injectable depot formulations J Shah US Patent App. 10/690,078, 2004 | 53 | 2004 |
| Influence of dosage form on the intravitreal pharmacokinetics of diclofenac C Durairaj, SJ Kim, HF Edelhauser, JC Shah, UB Kompella Investigative ophthalmology & visual science 50 (10), 4887-4897, 2009 | 52 | 2009 |
| Local delivery of vancomycin for the prophylaxis of prosthetic device-related infections DM Chilukuri, JC Shah Pharmaceutical research 22, 563-572, 2005 | 52 | 2005 |
